Conditions: Pain
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 26
Healthy volunteers: yes

Brief summary:
The main purpose of this study is to compare the pharmacokinetic profile to establish the better controlled liberation of the test product (Tramadol HCL OAD tablets of 200 mg, Labopharm) and its bioavailability in relation with the commercialised reference (Zytram® tablets of 200 mg, Zambon), single dose administered.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Tramadol Contramid OAD intervention 2: Zytram
Intervention descriptions: intervention 1: 1 Tramadol Contramid OAD 200 mg tablet as a single dose intervention 2: 1 Zytram 200 mg tablet as a single dose

Protocol document: